Arizona Attorney General Kris Mayes on Monday announced two major settlements totaling $17.85 million with pharmaceutical companies accused of conspiring to inflate prices on widely used generic medications.

The agreements — reached with Lannett Company Inc. and Bausch Health US, LLC/Bausch Health Americas Inc. — are part of a multistate effort involving 48 states and territories. The lawsuit alleged the companies worked together to artificially raise prices, limit competition, and restrain trade across numerous generic prescription drugs.

Mayes called the inflated prices “illegally high” and said the case highlights what she described as “the dark underbelly of corporate greed.”

“We’re not going to stop going after these greedy corporations who are rigging the system against hardworking Arizonans,” Mayes said. “There’s something particularly sinister about large pharmaceutical manufacturers rigging the system for medicine, which many times consumers have no choice but to continue to purchase. It’s gross.”

In addition to the settlements, Mayes announced that 42 states and territories, including Arizona, plan to file a new lawsuit against Novartis and its subsidiaries Sandoz Group AG and Sandoz AG. That case alleges a conspiracy to fix prices, divide markets, and rig bids for 31 generic drugs.

The actions stem from three large antitrust cases led by the Connecticut Office of the Attorney General, built on an extensive investigation involving more than 20 million documents and contact information for over 600 sales and pricing personnel in the generics industry.

Full settlement documents for the Lannett and Bausch cases are available online.